• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Amryt Pharma plc

    4/24/23 12:15:24 AM ET
    $AMYT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMYT alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: April 21, 2023
    Accession Number: 0001140361-23-018932
    Submission Type: POS AM
    CIK: 0001783010
    Company Name: Amryt Pharma plc
    File Number: 333-264869
    Get the next $AMYT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMYT

    DatePrice TargetRatingAnalyst
    9/6/2022$19.00Buy
    Canaccord Genuity
    3/10/2022$20.00 → $18.00Buy
    HC Wainwright & Co.
    3/10/2022$9.00 → $10.00Outperform
    SVB Leerink
    11/23/2021$23.00 → $19.00Outperform
    SVB Leerink
    10/4/2021$45.00Buy
    JonesTrading
    8/19/2021$22.00Outperform
    SVB Leerink
    8/19/2021$22.00Outperform
    Cowen
    7/27/2021$29.00Buy
    H.C. Wainwright
    More analyst ratings